These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6053696)

  • 21. Host-mediated antitumor action of schizophyllan, a glucan produced by Schizophyllum commune.
    Komatsu N; Okubo S; Kikumoto S; Kimura K; Saito G
    Gan; 1969 Apr; 60(2):137-44. PubMed ID: 5810959
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug resistance study in a mixed nitrogen mustard-sensitive-resistant tumour.
    Ujházy V
    Neoplasma; 1969; 16(4):467-8. PubMed ID: 5344233
    [No Abstract]   [Full Text] [Related]  

  • 23. Preparation of derivatives of nitrogen mustard having structure of alpha-amino acid amide.
    Sakurai Y; Matsui E
    Chem Pharm Bull (Tokyo); 1965 May; 13(5):594-8. PubMed ID: 5867717
    [No Abstract]   [Full Text] [Related]  

  • 24. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
    Sugiura K; Merker PC
    Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
    [No Abstract]   [Full Text] [Related]  

  • 25. PELVIC PERFUSION AND CARCINOMA OF THE RECTUM.
    PACE WG; KNOERNSCHILD H
    Am J Surg; 1965 Jan; 109():52-6. PubMed ID: 14248297
    [No Abstract]   [Full Text] [Related]  

  • 26. [Role of loco-regional chemotherapy in the treatment of tumors of the cervix].
    Scarabelli C; Savi C; Chiappino G; Temelcou O; Borghi AM
    Minerva Ginecol; 1977; 29(7-8):611-26. PubMed ID: 927739
    [No Abstract]   [Full Text] [Related]  

  • 27. [Tumour chemotherapy: syntheses of N-phosphorylated nitrogen mustards and related compounds].
    Kao WI; Ho HY; Song CW; Li MM; Cheng BL
    Yao Xue Xue Bao; 1965 Oct; 12(10):672-7. PubMed ID: 5898992
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacologic studies with trophosphamide (Ixoten), a new oxazaphosphorineoxide].
    Brock N
    Med Monatsschr; 1973 Sep; 27(9):390-4. PubMed ID: 4768197
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
    Schnabel R; Jungstand W; Gutsche W; Grimm H; Fritsch S
    Acta Biol Med Ger; 1967; 19(4):543-58. PubMed ID: 5596676
    [No Abstract]   [Full Text] [Related]  

  • 30. Isolation and characterization of nitrogen mustard-sensitive cells from a nitrogen mustard-resistant subline of Yoshida sarcoma.
    Isaka H; Izumitani M; Moriwaki A; Sakurai Y
    Gan; 1966 Aug; 57(4):353-66. PubMed ID: 5969489
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of nitrogen mustard sensitive and resistant Yoshida sarcomas. II. Effect of treatment on cell kinetics.
    Ball CR; Connors TA; Cooper EH; Topping NE
    Neoplasma; 1967; 14(3):253-64. PubMed ID: 6063004
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental studies on the antitumor effect of progesterone and enhancement of the therapeutic effect of anticancer drugs by progesterone--from the aspect of zinc metabolism].
    Ujiie S; Mimata Y; Okuno M; Wakui A
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2423-8. PubMed ID: 2751319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of heat to cancer chemotherapy--experimental studies.
    Suzuki K
    Nagoya J Med Sci; 1967 Jun; 30(1):1-21. PubMed ID: 6074086
    [No Abstract]   [Full Text] [Related]  

  • 34. The cytotoxic effect of plasmin on Yoshida sarcoma cells.
    Hilgard P; Hiemeyer V
    Rev Fr Etud Clin Biol; 1969 Nov; 14(9):902-4. PubMed ID: 4243799
    [No Abstract]   [Full Text] [Related]  

  • 35. Regional intravascular chemotherapy for experimental liver metastasis.
    Ichihashi H; Hisazaki M; Yasue M; Kondo T
    Nagoya J Med Sci; 1974 Mar; 36(2):63-9. PubMed ID: 4854065
    [No Abstract]   [Full Text] [Related]  

  • 36. [On chemotherapy of neoplasms with regional perfusion].
    Husvéti S; Besznyák I
    Acta Chir Acad Sci Hung; 1966; 7(4):351-9. PubMed ID: 5965423
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experimental studies on the optimal therapeutic mode of intra-arterial infusion of 5-fluorouracil. (1) Preparation of an animal model for continuous intra-arterial infusion and comparison of the therapeutic and adverse effects of 5-fluorouracil delivered by various modes].
    Ota J
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2353-61. PubMed ID: 6639097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perfusion with chemotherapeutic agents for malignancy. Anesthetic problems in extracorporeal perfusion with chemotherapeutic agents for malignancy.
    Grosshandler S; Henschel EO; Jacoby J
    Neoplasma; 1965; 12(6):645-52. PubMed ID: 5863237
    [No Abstract]   [Full Text] [Related]  

  • 39. A new antitumour agent: phenazathionium-mustard salt.
    Csaba G; Körösi J
    Neoplasma; 1968; 15(4):443-5. PubMed ID: 5684468
    [No Abstract]   [Full Text] [Related]  

  • 40. Antitumor effect of 2-thio-4-hydrazinouracil on transplantable tumors.
    Golovinsky EV; Emanuilov EA; Spassovska NC; Spassov AV
    Neoplasma; 1975; 22(3):255-8. PubMed ID: 1161120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.